Jones Elaine V — SEC Form 4 filings
SEC reporting owner CIK 1296907. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-17 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | Director | 2 | — | — | 7 |
| CytomX Therapeutics, Inc. (CTMX) | Director | 3 | — | — | 3 |
| NextCure, Inc. (NXTC) | Director | 3 | — | — | 3 |
Form 4 filings — Jones Elaine V
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 2,340 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 59,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-04-08 | 4 | Gritstone bio, Inc. (GRTS) | Other (J): 51,800 (derivative) @ $0 · Other (J): 51,800 (derivative) @ $0 · Other (J): 19,000 (derivative) @ $0 · Other (J): 19,000 (derivative) @ $0 · Other (J): 12,500 (derivative) @ $0 · Other (J): 15,942 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | NextCure, Inc. (NXTC) | Grant/award (A): 18,700 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 51,800 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | CytomX Therapeutics, Inc. (CTMX) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296907 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →